Implementing Low-Barrier HCV Treatment in a Jail Setting
Recruiting
Phase 4
Interventional Study
HEPATITIS C (HCV)
Incarceration
Injection Drug Use
Implementation Science
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Lifespan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn whether a low-barrier treatment program can help people with hepatitis C virus (HCV) who are in jail start and complete treatment more easily. This study focuses on adults at the Rhode Island Department of Corrections who have active HCV and are awaiting trial.
The study asks:
* Can a simplified, low-barrier HCV treatment program work in a jail setting…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Incarcerated individual at RIDOC
* Age ≥ 18 years
* Awaiting trial (i.e., not sentenced)
* English speaking
* Diagnosis of active HCV (HCV RNA \>1000 IU/mL within 90 days prior to study entry)
* Treatment-naïve for current HCV infection
* No cirrhosis (FIB-4 Score \<3.25 withi…
Contacts
No contact information available.